Share-based Compensation (Tables)

12 Months Ended

Dec. 31, 2021

Share-based Payment Arrangement [Abstract]

Summary of consolidated stock-based compensation expense, by type of awards

	For the Years Ended
	December 31,		December 31,		December 31,
	2021		2020		2019
Employee stock options	$	4,593	$	315	$	305
Restricted share grants		1,196		–		516
Total share-based compensation expense	$	5,789	$	315	$	821

Summary of consolidated stock-based compensation by line items

	For the Years Ended
	December 31, 2021		December 31, 2020		December 31, 2019
General and administrative	$	5,771	$	296	$	768
Sales, marketing and customer service		18		19		53
Total share-based compensation expense, net of nil income taxes	$	5,789	$	315	$	821

Summary of assumptions used in the determination of the fair value of share-based payment awards using the Black-Scholes model for stock option grants

	For the Years Ended
	December 31, 2021		December 31, 2020		December 31, 2019
Expected term		6.25		6.25		6.25
Risk-free interest rate		0.11%-0.16%		0.07%-0.09%		1.55%-2.51%
Expected volatility		713%-719%		537%-762%		575%-605%
Expected dividend yield		0%		0%		0%

(b)       2021 Omnibus Equity Incentive Plan

	For the Years Ended
	December 31, 2021		December 31, 2020		December 31, 2019
Expected term		1-3 years		–		–
Risk-free interest rate		1.52%		–		–
Expected volatility		64.4% to 69.0%		–		–
Expected dividend yield		0%		–		–

(c)       2021 SolarJuice Equity Incentive Plan

	For the Years Ended
	December 31, 2021		December 31, 2020		December 31, 2019
Expected term		3 years		–		–
Risk-free interest rate		1.52%		–		–
Expected volatility		45.3%		–		–
Expected dividend yield		0%		–		–

Summary of stock option activities

	Shares			Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Term		Aggregate Intrinsic Value ($000)
Outstanding as of January 1, 2019		260,200			212		8.59	$	–
Granted		65,000			3
Exercised		–			–
Forfeited/expired		(70,000	)		4
Outstanding as of December 31, 2019		255,200			19		6.70	$	–
Granted		300,000			9
Exercised		(109,500	)		4
Forfeited/expired		(56,800	)		27
Outstanding as of December 31, 2020		388,900			11		7.52	$	486
Granted		969,000			7
Exercised		(25,000	)		4
Forfeited/expired		(117,000	)		10
Outstanding as of December 31, 2021		1,215,900			8		9.04	$	82
Exercisable as of December 31, 2021		113,900			16		7.45	$	27
Non-vested as of December 31, 2021		1,102,000			7		9.21	$	55

Summary of exercise price and remaining life information about options exercisable

Range of exercise price	Shares Exercisable		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price		Aggregate Intrinsic ($000)
$118 - $172		1,000		3.17	$	172.00		–
$40 - $117		12,600		4.41	$	62.04		–
$3 - $39		87,800		7.88	$	9.23		1
$1-$2		12,500		7.85	$	1.61		26
		113,900						27

Summary of restricted stock awards

	Number of Shares			Weighted Average Grant-Date Fair Value
Outstanding at January 1, 2019		1,250		$	185
Granted		107,000		$	3
Vested		(108,250	)	$	5
Restricted stock units at December 31, 2019		–			–
Granted		–			–
Vested		–			–
Restricted stock units at December 31, 2020		–			–
Granted		184,000		$	6.34
Vested		(184,000	)	$	6.34
Restricted stock units at December 31, 2021		–			–

Schedule of Phoenix’s stock option activities

	Shares		Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Term		Aggregate Intrinsic Value ($000)
Outstanding as of December 31, 2020		–		–		–	$	–
Granted		2,040,500	$	1.72
Exercised		–
Forfeited/expired		(354,000)	$	1.72
Outstanding as of December 31, 2021		1,686,500	$	1.72		9.45	$	3,204
Exercisable as of December 31, 2021		–
Non-vested as of December 31, 2021		1,686,500	$	1.72		9.45	$	3,204

Schedule of SJ group stock option activities

	Shares		Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Term		Aggregate Intrinsic Value ($000)
Outstanding as of December 31, 2020		–		–		–	$	–
Granted		6,117,160	$	0.48
Exercised		–
Forfeited/expired		(1,652,860)	$	0.48
Outstanding as of December 31, 2021		4,464,300	$	0.48		9.44	$	1,607
Vested and exercisable as of December 31, 2021		–
Non-vested as of December 31, 2021		4,464,300	$	0.48		9.44	$	1,607